fashion -WSS

fashion

author：entertainment 2025-10-02 14:22:51 - browse：2

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Thermo Fisher plant for manufacturing gene therapies to expand

WSS

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Flagship Pioneering startup Sonata Therapeutics lays off 21

Senators: Long

Surprise medical billing ban raises prices elsewhere

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Reporting on presidential health from Reagan to Trump and Biden

knowledge

fashion

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Abridge raises $150m as clinical notes automation market heats up

Activists slam private health insurers over coverage restrictions

Researchers tackle phage therapy hurdles for wider adoption

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

WATCH: Why do our ears pop?

Dobbs anniversary: the lost opportunity of abortion as health care

Elevance, SCAN deals highlight health insurer acquisition scrutiny

leisure time

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Hearing on Medicare drug price negotiation gets unusually heated

Readout LOUD podcast: possible new ALS drug, artificial wombs

Obamacare plans could cover weight loss drugs

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Thermo Fisher plant for manufacturing gene therapies to expand

focus

knowledge

explore

hotspot